Novasecta

Last week, we hosted our second pharmaceutical networking breakfast in Copenhagen.   We had a good discussion on the subject of 'Decision-making in Pharma', where we identified important elements of successful decision-making, including:   🎯Alignment on the strategic focus through all layers of the organisation 🤝Leaders that trust and empower their teams to make decisions 🔎Systematically evaluating the options for key decisions and their expected outcomes 💡Active engagement from all those present in decision-making discussions 🔊Communication of roles, accountabilities and decisions through project teams We also discussed the challenge of embedding the right culture and mindset for effective decision-making.   It was great to hear diverse perspectives from Tarek Samad, Tine Bryan Stensbøl, Fanny Longin and Marie Dagnaud. Thank you for an insightful discussion!   We look forward to discussing another important topic at our next networking breakfast. Please contact Andrew Bell to request an invitation to our next event.

How can pharma companies successfully embed integrated and open innovation? In this white paper, we explore the ways that companies can successfully apply both an integrated and open innovation approach to their R&D and commercial activities, with an emphasis on: - Open innovation approaches that reach beyond traditional one-to-one partnering and licensing - Important challenges of effective integrated and open innovation: finding quality, embracing the outside, and managing the integration of the outside and inside - Ways to overcome these challenges to effectively embrace innovation Click here to download: https://lnkd.in/eyMDM8KG #Innovation #ExternalInnovation #RandD #Commercial #MidPharmas #Pharma #Strategy #Consulting

Focused external innovation is critical for innovative pharma that are striving to grow their R&D pipelines. Novasecta supports pharma in creating external innovation business plans with focused investments, capabilities, and processes to enrich R&D pipelines. Read this and other client stories here: https://lnkd.in/e-me4PcT

Successful partnerships can fuel transformative growth for pharma and biotech of all sizes. 🤝 We accelerate our clients' access to relevant partners by strategically screening our senior network and helping to communicate their unique proposition. Read more client stories here: https://lnkd.in/e-me4PcT

How can pharma companies increase R&D productivity?💡   In this MedNous (Evernow Publishing Ltd) article, we explore key insights from our annual MidPharma R&D Symposium, attended by 13 R&D leaders from 9 European-headquartered MidPharmas.   The lively discussion focused on how to improve R&D productivity at a system level. We discussed practical methods to drive R&D productivity through changes to ways of working and operating models, across three key topics:    - Enhancing productivity of the project-function matrix  - Optimising decision-making and capabilities  - Blending external and internal innovation   Download the article here: https://lnkd.in/eYSNnexR #ResearchandDevelopment #Novasecta #MidPharmas #Pharma #Pharmaceuticals #Biopharma #Symposium #RandD #RandDProductivity #MedNous

Novasecta Biotech Symposium October 2024 Novasecta is delighted to be hosting our first face-to-face Biotech Symposium in London on 16th and 17th October 2024: a private multi-company meeting for Biotech leaders who share the desire to be better at what they do. We will discuss how to navigate the evolving biotech landscape, starting with a networking dinner on the evening of the 16th and facilitated discussions on the 17th. If you are a leadership team member in a Biotech and would like to join us, please contact John Gregson for more details and to request an invitation. #Biotech #Biopharma #Novasecta #Symposium #Partnering #SecuringInvestment #OperationalExcellence 

Novasecta supports biotech and pharma clients to find the right partners and create effective BD strategies. Read this client success story and others on our website 💡 https://lnkd.in/eX9CyrFK #pharma #biotech #pharmaceuticals #strategy #businessdevelopment #bd #partnering

Organisational complexity and scale are two sides of the same coin. In a quest for scale, Big Pharma companies have built large, diverse portfolios that span multiple therapeutic areas and technologies. But this comes with its own set of challenges. In this white paper we explore how organisational complexity is driven by scale and portfolio diversity, and illustrate the need for operational excellence when pursuing sustainable growth, with a focus on: 🎯 How portfolio diversity drives financial performance and organisational complexity 📈How pharmaceutical companies can both grow and manage complexity 💡 The key learnings for pharma leaders to embed operational excellence Download the white paper here: https://lnkd.in/eTuUy_Gq #Pharma #Pharmaceuticals #PharmaceuticalStrategy #Biopharma #Strategy #Consulting #OperationalExcellence #Leadership #Profitability #Complexity

We explore how pharmaceutical companies of all sizes can improve decision-making by creating effective governance processes and empowering cross-functional teams. To find out how we support companies to reimagine governance models, read our client story below. Find more client stories about effective decision-making here: https://lnkd.in/e-me4PcT

🔎Leading pharmaceutical companies must navigate the complexity that comes with scaling and diversifying their portfolios   In this MedNous article, we explore how six industry leading Big Pharmas successfully manage organisational complexity. We analyse the unique approaches of Novo Nordisk, Gilead Sciences, AstraZeneca, Eli Lilly and Company, Novartis and Sanofi, grounded in maintaining strategic focus and establishing fit for purpose operating models.   Read the full article here: https://lnkd.in/esGtPTbZ #Pharma #Pharmaceuticals #PharmaceuticalStrategy #Biopharma #Strategy #Consulting #OperationalExcellence #Leadership #Profitability #Complexity